1. Hoots, B., Vivolo-Kantor, A., Seth, P. The rise in non-fatal and fatal overdoses involving stimulants with and without opioids in the United States. Addiction. 2020;115(5):946-958.doi:10.1111/add.14878 31912625
Google Scholar | Crossref | Medline2. Gladden, RM., O’Donnell, J., Mattson, CL., Seth, P. Changes in opioid-involved overdose deaths by opioid type and presence of benzodiazepines, cocaine, and methamphetamine—25 states, July–December 2017 to January–June 2018. MMWR Morb Mortal Wkly Rep. 2019;68(34):737-744.doi:10.15585/mmwr.mm6834a2 31465320
Google Scholar | Crossref | Medline3. West, E., Cameron, P., O’Reilly, G., Drummer, OH., Bystrzycki, A. Accuracy of current clinical diagnosis in recreational drug-related attendance to the emergency department. Emerg Med Australas. 2008;20(4):333-338.doi:10.1111/j.1742-6723.2008.01110.x 18782207
Google Scholar | Medline4. Boyer, EW . Management of opioid analgesic overdose. N Engl J Med. 2012;367(2):146-155.doi:10.1056/NEJMra1202561 22784117
Google Scholar | Crossref | Medline | ISI5. Gurney, SMR., Scott, KS., Kacinko, SL., Presley, BC., Logan, BK. Pharmacology, toxicology, and adverse effects of synthetic cannabinoid drugs. Forensic Sci Rev. 2014;26(1):53-78.26226970
Google Scholar | Medline6. Pourmand, A., Mazer-Amirshahi, M., Chistov, S., Li, A., Park, M. Designer drugs: review and implications for emergency management. Hum Exp Toxicol. 2018;37(1):94-101.doi:10.1177/0960327117698542 28764574
Google Scholar | SAGE Journals | ISI7. Roberts, JR . InFocus: acetyl fentanyl: new drug of abuse more common than assumed. Emerg Med News. 2013;35(12):28-29.doi:10.1097/01.EEM.0000440686.75528.a2
Google Scholar8. Singh, VM., Browne, T., Montgomery, J. The emerging role of toxic adulterants in street drugs in the US illicit opioid crisis. Public Health Rep. 2020;135(1):6-10.doi:10.1177/0033354919887741 31738861
Google Scholar | SAGE Journals | ISI9. Wu, AHB., McKay, C., Broussard, LA et al. National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: recommendations for the use of laboratory tests to support poisoned patients who present to the emergency department. Clin Chem. 2003;49(3):357-379.doi:10.1373/49.3.357 12600948
Google Scholar | Crossref | Medline10. Centers for Disease Control and Prevention . CDC’s Laboratory Response Network for Chemical Threats. . https://emergency.cdc.gov/lrn/chemical.asp
Google Scholar11. LaRue, L., Twillman, RK., Dawson, E et al. Rate of fentanyl positivity among urine drug test results positive for cocaine or methamphetamine. JAMA Netw Open. 2019;2(4):e192851. doi:10.1001/jamanetworkopen.2019.2851 31026029
Google Scholar | Crossref | Medline12. Twillman, RK., Dawson, E., LaRue, L., Guevara, MG., Whitley, P., Huskey, A. Evaluation of trends of near–real-time urine drug test results for methamphetamine, cocaine, heroin, and fentanyl. JAMA Netw Open. 2020;3(1):e1918514. doi:10.1001/jamanetworkopen.2019.18514 31899527
Google Scholar | Crossref | Medline13. Coutinho, S., Wright, N. Nonfatal Hospital-Treated Drug Overdose Surveillance and Epidemiology (DOSE) Summary. Minnesota Department of Health; 2020.
Google Scholar14. Minnesota Compass . Northland Region data. 2020. . http://www.mncompass.org/profiles/region/northland
Google Scholar15. DeLaquil, M . Differences in Rates of Drug Overdose Deaths by Race. Minnesota Department of Health; 2020. . https://www.health.state.mn.us/communities/opioids/documents/raceratedisparity2019prelimfinal.pdf
Google Scholar16. US Drug Enforcement Administration . 2019 National Drug Threat Assessment. US Department of Justice, Drug Enforcement Administration; December 2019. . https://www.dea.gov/documents/2020/2020-01/2020-01-30/2019-national-drug-threat-assessment
Google Scholar17. Cole, C., Jones, L., McVeigh, J., Kicman, A., Syed, Q., Bellis, M. Adulterants in illicit drugs: a review of empirical evidence. Drug Test Anal. 2011;3(2):89-96.doi:10.1002/dta.220 21322119
Google Scholar | Crossref | Medline18. Arens, AM., van Wijk, XMR., Vo, KT., Lynch, KL., Wu, AHB., Smollin, CG. Adverse effects from counterfeit alprazolam tablets. JAMA Intern Med. 2016;176(10):1554-1555.doi:10.1001/jamainternmed.2016.4306 27532131
Google Scholar | Crossref | Medline19. Wish, ED., Billing, AS., Artigiani, EE., Dezman, Z., Schwartz, B., Pueschel, J. Drug Early Warning From Re-Testing Biological Samples: Maryland Hospital Study. Office of National Drug Control Policy, Executive Office of the President; 2018.
Google Scholar20. Evrard, I., Legleye, S., Cadet-Taïrou, A. Composition, purity and perceived quality of street cocaine in France. Int J Drug Policy. 2010;21(5):399-406.doi:10.1016/j.drugpo.2010.03.004 20378323
Google Scholar | Crossref | Medline21. Lee, KC., Ladizinski, B., Federman, DG. Complications associated with use of levamisole-contaminated cocaine: an emerging public health challenge. Mayo Clin Proc. 2012;87(6):581-586.doi:10.1016/j.mayocp.2012.03.010 22677078
Google Scholar | Crossref | Medline | ISI22. Miller, JM., Stogner, JM., Miller, BL., Blough, S. Exploring synthetic heroin: accounts of acetyl fentanyl use from a sample of dually diagnosed drug offenders. Drug Alcohol Rev. 2018;37(1):121-127.doi:10.1111/dar.12502 28349617
Google Scholar | Crossref | Medline23. Stogner, JM . The potential threat of acetyl fentanyl: legal issues, contaminated heroin, and acetyl fentanyl “disguised” as other opioids. Ann Emerg Med. 2014;64(6):637-639.doi:10.1016/j.annemergmed.2014.07.017 25153008
Google Scholar | Crossref | Medline24. Moallef, S., Nosova, E., Milloy, MJ et al. Knowledge of fentanyl and perceived risk of overdose among persons who use drugs in Vancouver, Canada. Public Health Rep. 2019;134(4):423-431.doi:10.1177/0033354919857084 31211644
Google Scholar | SAGE Journals | ISI25. Adams, AJ., Banister, SD., Irizarry, L., Trecki, J., Schwartz, M., Gerona, R. “Zombie” outbreak caused by the synthetic cannabinoid AMB-FUBINACA in New York. N Engl J Med. 2017;376(3):235-242.doi:10.1056/NEJMoa1610300 27973993
Google Scholar | Crossref | Medline26. Sharma, P., Murthy, P., Bharath, MMS. Chemistry, metabolism, and toxicology of cannabis: clinical implications. Iran J Psychiatry. 2012;7(4):149-156.23408483
Google Scholar | Medline